ALS Therapy Development Institute

ALS Therapy Development Institute
Abbreviation	ALS TDI
Founded	1999
Founder	James Heywood; Robert Bonazoli; Melinda Marsh Heywood;
Type	non-profit biotech
Tax ID no.	04-3462719
Location	Watertown, Massachusetts, United States;
Key people	Augie Nieto (chairman of the board); Steven Perrin, PhD (vice chairman of the board); Fernando Vieira, M.D. (chief executive officer and chief scientific officer);
Affiliations	International Alliance of ALS/MND Associations
Website	als.net

The ALS Therapy Development Institute (ALS TDI) is a non-profit biotechnology research organization focused on finding treatments for amyotrophic lateral sclerosis (ALS). With a staff including more than 30 scientists, it operates a research and development program centered on ALS.^[1]^[2]

^ "'Ice Bucket Challenge' Expedites Cambridge Institute's ALS Drug Trial". CBS Boston. 2014-08-27. Retrieved 2018-02-07.
^ Cite error: The named reference :0 was invoked but never defined (see the help page).

[:1-1] "'Ice Bucket Challenge' Expedites Cambridge Institute's ALS Drug Trial". CBS Boston. 2014-08-27. Retrieved 2018-02-07.

[:0-2] Cite error: The named reference :0 was invoked but never defined (see the help page).

[1]

[2]